Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...

In its petition, Novo Nordisk says that the Outsourcing Facilities Association (OFA), a trade organisation representing the compounding pharmacy industry, has incorrectly nominated liraglutide on ...

The FDA authorizes companies to offer compounded versions of GLP-1s and ... offerings such as oral-based weight loss medications and liraglutide, another GLP-1 injection drug.

Another factor to consider in the introduction of Liraglutide in mid-2025. This is a compounded version of Novo's Saxenda. Pricing of liraglutide is expected to be in the ~$200/month range vs the ...